# clm_7149A1CA2203

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 362,802,000 United States dollar  
valid_from: 2016-09-30  
valid_to: 2017-03-31  
published: 2016-11-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0981CA086973  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly operating income: 362,802,000 United States dollar", as of 2016-09-30 (until 2017-03-31). Claim clm_7149A1CA2203, https://asof.is/claim/clm_7149A1CA2203, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-11-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217616000082/0001532176-16-000082-index.htm (primary, SEC EDGAR 10-Q Q3 FY2016, published 2016-11-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 291,628,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_7149A1CA2203](/claim/clm_7149A1CA2203.md) | [clm_7203835AF9D6](/claim/clm_7203835AF9D6.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.